Your browser doesn't support javascript.
loading
Patient considerations in the use of transdermal iontophoretic fentanyl for acute postoperative pain.
Hartrick, Craig T; Pestano, Cecile R; Ding, Li; Danesi, Hassan; Jones, James B.
Afiliação
  • Hartrick CT; Beaumont Health System, Troy, MI, USA.
  • Pestano CR; Beaumont Health System, Troy, MI, USA.
  • Ding L; The Medicines Company, Parsippany, NJ, USA.
  • Danesi H; The Medicines Company, Parsippany, NJ, USA.
  • Jones JB; The Medicines Company, Parsippany, NJ, USA.
J Pain Res ; 9: 215-22, 2016.
Article em En | MEDLINE | ID: mdl-27186073
ABSTRACT
Opioids are commonly used in the management of moderate-to-severe postoperative pain. Patient-controlled analgesic techniques are recognized as preferred administration methods. Previously, research has focused on intravenously administered opioids via a programmable pump. More recently, an iontophoretic transdermal system (ITS), which is patient controlled, has been developed. The focus of this review is on pain management using the fentanyl ITS during the 24-72-hour time period immediately following surgery. Fentanyl ITS offers a needle-free alternative to traditional intravenous (IV) patient-controlled analgesia (PCA) system that is as effective and safe as IV PCA. This system is easy to use for both patients and nurses. The use of fentanyl ITS is generally associated with a better ease-of-care profile, including a greater ease of mobility, from a patients' perspective when compared with morphine IV PCA.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article